Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. Death and dysfunction of these cells cause vision loss in conditions like glaucoma and multiple sclerosis. The laboratory process is described in the journal Scientific Reports.
Work could eventually lead to cell transplants for people blinded by glaucoma, MS
November 30, 2015
Gene Therapy Genetics Glaucoma Neuroscience Optic Nerve Disorders Regenerative Medicine Retina Stem Cells